StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories established Pharmaceutical Products — Segment Operating Earnings ($M) ($M)

Postgres DB segment_values + Form 10-K/10-Q XBRL

Latest, FY2025
1,290
Period ended Dec 31, 2025
Change on a year earlier
+4.6%
1,233 in FY2024
History
13 years
Since FY2013
Sources
11
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedEstablished Pharmaceutical Products — Segment Operating Earnings ($M) ($M)Year on yearSource
FY2025Dec 31, 20251,290+4.6%Form 10-K (filed 2026-02-20) ↗
FY2024Dec 31, 20241,233+2.2%Form 10-K (filed 2025-02-21) ↗
FY2023Dec 31, 20231,206+15.0%Form 10-K (filed 2024-02-16) ↗
FY2022Dec 31, 20221,049+18.0%Form 10-K (filed 2023-02-17) ↗
FY2021Dec 31, 2021889+12.0%Form 10-K (filed 2022-02-18) ↗
FY2020Dec 31, 2020794-12.2%Form 10-K (filed 2021-02-19) ↗
FY2019Dec 31, 2019904+1.1%Form 10-K (filed 2020-02-21) ↗
FY2018Dec 31, 2018894+5.4%Form 10-K (filed 2019-02-22) ↗
FY2017Dec 31, 2017848+17.3%Form 10-K (filed 2018-02-16) ↗
FY2016Dec 31, 2016723+9.9%Form 10-K (filed 2017-02-17) ↗
FY2015Dec 31, 2015658+5.4%Form 10-K (filed 2016-02-19) ↗
FY2014Dec 31, 2014624+13.2%Form 10-K (filed 2016-02-19) ↗
FY2013Dec 31, 2013551–Form 10-K (filed 2016-02-19) ↗

Cite this data

StockData. (2026). Abbott Laboratories Established Pharmaceutical Products — Segment Operating Earnings ($M) ($M), annual FY2013–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/db-seg-opinc-epd

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.